CVS/Aetna deal likely won’t improve prescription drug prices
Published Updated
3 Min Read
More From Employee Benefit News
What Trump’s ‘Great Healthcare Plan’ means for drug costs and price transparency
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
US, UK announce deal on pharmaceutical tariffs and drug pricing
The U.S. agreed to exempt U.K. pharmaceutical products from tariffs.
Cigna will end drug rebates in many private health plans
The plan to eventually phase out rebates portends a seismic shift in the flow of billions of dollars among drugmakers, insurers and employers.
CVS is offering a $200 Wegovy copay in an effort to expand coverage
This is the latest move by pharmacy benefit managers to deal with the surging demand for weight-loss medicine.
State of Pharmacy Management
The pharmacy landscape is shifting rapidly—and employers are feeling the pressure.
